M. Favier

703 total citations
19 papers, 446 citations indexed

About

M. Favier is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, M. Favier has authored 19 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Molecular Biology. Recurrent topics in M. Favier's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (5 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). M. Favier is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (5 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). M. Favier collaborates with scholars based in France, Canada and Netherlands. M. Favier's co-authors include Marc Savasta, Carole Carcenac, Sébastien Carnicella, Guillaume Drui, Sabrina Boulet, Anne Bertrand, Michiel van Genuchten, T.M.A. Bemelmans, A.F. Rutkowski and Doug Vogel and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Trends in Pharmacological Sciences.

In The Last Decade

M. Favier

19 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Favier France 8 221 188 65 56 41 19 446
Rachel C. Lazarus United States 8 78 0.4× 47 0.3× 88 1.4× 84 1.5× 11 0.3× 9 497
Mary C. Anderson United States 13 62 0.3× 98 0.5× 285 4.4× 83 1.5× 10 0.2× 18 1.3k
Lauren T. Brown United States 7 275 1.2× 150 0.8× 91 1.4× 160 2.9× 3 0.1× 7 648
Maria Stavrou United Kingdom 7 109 0.5× 29 0.2× 24 0.4× 56 1.0× 5 0.1× 13 368
Ben Jones United States 6 79 0.4× 186 1.0× 37 0.6× 155 2.8× 10 0.2× 18 548
Ana Paula Correia Portugal 10 201 0.9× 59 0.3× 8 0.1× 46 0.8× 14 0.3× 28 602
Anh Thi Nguyen Vietnam 10 170 0.8× 52 0.3× 10 0.2× 141 2.5× 8 0.2× 53 654
Lizhuang Yang China 19 42 0.2× 46 0.2× 285 4.4× 192 3.4× 36 0.9× 58 899
Pontus Plavén‐Sigray Sweden 17 49 0.2× 174 0.9× 183 2.8× 113 2.0× 3 0.1× 38 752

Countries citing papers authored by M. Favier

Since Specialization
Citations

This map shows the geographic impact of M. Favier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Favier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Favier more than expected).

Fields of papers citing papers by M. Favier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Favier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Favier. The network helps show where M. Favier may publish in the future.

Co-authorship network of co-authors of M. Favier

This figure shows the co-authorship network connecting the top 25 collaborators of M. Favier. A scholar is included among the top collaborators of M. Favier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Favier. M. Favier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Salvetat, Nicolas, M. Favier, Diana Vetter, et al.. (2024). RNA Editing Signatures Powered by Artificial Intelligence: A New Frontier in Differentiating Schizophrenia, Bipolar, and Schizoaffective Disorders. International Journal of Molecular Sciences. 25(23). 12981–12981. 1 indexed citations
2.
Favier, M., Carole Carcenac, Marc Savasta, & Sébastien Carnicella. (2022). Dopamine D3 Receptors: A Potential Target to Treat Motivational Deficits in Parkinson’s Disease. Current topics in behavioral neurosciences. 60. 109–132. 4 indexed citations
3.
Favier, M., Nicolas Pietrancosta, Salah El Mestikawy, & Giuseppe Gangarossa. (2021). Leveraging VGLUT3 Functions to Untangle Brain Dysfunctions. Trends in Pharmacological Sciences. 42(6). 475–490. 8 indexed citations
4.
Mestikawy, Salah El & M. Favier. (2021). Troubles des conduites alimentaires. médecine/sciences. 37(8-9). 719–721. 1 indexed citations
5.
Smart, Kelly, Atsuko Nagano‐Saito, M. Favier, et al.. (2021). Metabotropic glutamate type 5 receptor binding availability during dextroamphetamine sensitization in mice and humans. Journal of Psychiatry and Neuroscience. 46(1). E1–E13. 5 indexed citations
6.
Favier, M., Carole Carcenac, Guillaume Drui, et al.. (2017). Implication of dorsostriatal D3 receptors in motivational processes: a potential target for neuropsychiatric symptoms in Parkinson’s disease. Scientific Reports. 7(1). 41589–41589. 15 indexed citations
7.
Favier, M., Carole Carcenac, Marc Savasta, & Sébastien Carnicella. (2017). Motivation et apathie parkinsonienne. médecine/sciences. 33(10). 822–824. 2 indexed citations
8.
Carcenac, Carole, M. Favier, Yvan M. Vachez, et al.. (2015). Subthalamic deep brain stimulation differently alters striatal dopaminergic receptor levels in rats. Movement Disorders. 30(13). 1739–1749. 24 indexed citations
9.
Carnicella, Sébastien, Guillaume Drui, Sabrina Boulet, et al.. (2014). Implication of dopamine D3 receptor activation in the reversion of Parkinson’s disease-related motivational deficits. Translational Psychiatry. 4(6). e401–e401. 60 indexed citations
10.
Favier, M., et al.. (2014). Pramipexole reverses Parkinson's disease‐related motivational deficits in rats. Movement Disorders. 29(7). 912–920. 46 indexed citations
11.
Favier, M., Carole Carcenac, Guillaume Drui, et al.. (2013). High-frequency stimulation of the subthalamic nucleus modifies the expression of vesicular glutamate transporters in basal ganglia in a rat model of Parkinson’s disease. BMC Neuroscience. 14(1). 152–152. 17 indexed citations
12.
Drui, Guillaume, Sébastien Carnicella, Carole Carcenac, et al.. (2013). Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson’s disease. Molecular Psychiatry. 19(3). 358–367. 160 indexed citations
13.
Hininger‐Favier, Isabelle, et al.. (2012). Nutrition et femme enceinte. 7(1). 1–13. 6 indexed citations
14.
Favier, M., et al.. (2007). Le nouveau défi des équipes virtuelles : construire et maintenir une connaissance mutuelle. HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations
15.
Rutkowski, A.F., Doug Vogel, Michiel van Genuchten, T.M.A. Bemelmans, & M. Favier. (2002). e-collaboration: the reality of virtuality. IEEE Transactions on Professional Communication. 45(4). 219–230. 88 indexed citations
16.
Favier, M. & Isabelle Hininger‐Favier. (1997). [Trace elements: zinc, copper, selenium, chromium. Consequences of a deficiency, of excessive trace elements, and value of systematic supplementation].. PubMed. 26(3 Suppl). 109–14. 3 indexed citations
17.
Favier, M., et al.. (1990). [Role of zinc deficiency in the etiology of neural tube malformations].. PubMed. 85(1). 49–55. 3 indexed citations
18.
Cohen, Adi, et al.. (1988). [Lutenyl and menstrual disorders. A hospital study].. PubMed. 83(11). 741–3. 1 indexed citations
19.
Bayle, François, et al.. (1986). [Pregnancy in a renal transplant patient under a triple immunosuppressive combination: cyclosporin A, azathioprine and prednisone].. PubMed. 15(6). 259–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026